After Aphria Deal, the New Tilray Eyes Global Cannabis Brands
May 04 2021, 7:49 AM
May 03 2021, 9:11 PM
May 04 2021, 7:49 AM
(Bloomberg) Tilray Inc. shareholders approved the merger with Aphria Inc., creating a cannabis powerhouse thatâs both the largest medical marijuana company in Europe and a major player in Canadaâs recreational market.
(Bloomberg) Tilray Inc. shareholders approved the merger with Aphria Inc., creating a cannabis powerhouse thatâs both the largest medical marijuana company in Europe and a major player in Canadaâs recreational market.
The companyâs ambitions donât end there, though.
Irwin Simon, the former head of Aphria who is now chairman and chief executive officer of the combined company, has ambitions to transform it from an edgy Canadian marijuana company into a global consumer products giant, potentially selling cannabis in everything from drinks to skin creams to snack bars.